Upload
dinhthuy
View
213
Download
0
Embed Size (px)
Citation preview
1
Accurate clinical dosimetry
Part I:Fundamentals and
New developments in reference dosimetry
Jan SeuntjensMcGill University
Montreal, Canada, H3G [email protected]
Accurate clinical dosimetry, Part I, 2008 1
Dosimetric accuracy requirement
• effect of doseuncertainty oncomplication-freetumour control (“utilityfunction”, Schultheiss &Boyer, 1988)
• ICRU Report 24 (1976)• Mijnheer et al (1987)• Brahme (1988)
1% higher accuracy
→ 2% increase of cure
5%
3.5%
3%The structures these numbers are referring to are targets volumes
Accurate clinical dosimetry, Part I, 2008 2
Dosimetric and positional accuracy of TPA: acceptability criteria
4 mm
4 mm
4 mm
large dosegradient
4%
3%
3%
high doseregion
low dosegradient
3% (50%loc.dose)
antropomorphicphantom and/orcomplex beams
3% (50%loc.dose)3%Stack of tissue
slabs simple fields
3% (50%loc.dose)2%
Homogeneouswater slab -simple fields
low doseregion
low dosegradient
centralaxis
Van Dyk (1993)
Accurate clinical dosimetry, Part I, 2008 3
How accurately can we measure dose clinically?
• Which accuracy do we expect for a given clinicalsituation?
• How should we measure dose accurately?– when is a situation “well-behaved”?– when do we have non-equilibrium conditions?
• What is a suitable detector?• How do we handle complication areas?
– build-up region– narrow stereotactic beams– modulated fields and dynamic time-dependent measurement
2
Accurate clinical dosimetry, Part I, 2008 4
Outline
• Principles of measurement dosimetry• Detectors and phantoms• Reference dosimetry in TG51 compliant
beams• Issues in non-equilibrium dosimetry
– Relative dosimetry in non-equilibrium situations– Reference dosimetry in TG-51 non-compliant
beams
Accurate clinical dosimetry, Part I, 2008 5
Classification of dosimetersDosimeter Mechanism
Gas-filled ionization chamber Ionization in gasses
Liquid ionization chamber Ionization in liquids
Semiconductors (diodes,diamond detectors,MOSFET)
Ionization in solids
TLD Luminescence
Scintillation counters Fluorescence
Film, gel, Fricke Chemical reactions
Calorimetry Heat
Accurate clinical dosimetry, Part I, 2008 6
Measurement dosimetry in medium
where:
dose to medium at the point
raw signal, corrected for environmentalconditions as given by detector
detector cavity dose calibration coefficient(coupling constant)
dose conversion coefficient converts averagedetector dose into dose to medium at point
Dmed (r ) = cdetM(r )fmed (r )
Dmed (r )
M(r )
fmed (r )
cdet
Accurate clinical dosimetry, Part I, 2008 7
Dosimeter dependent coefficients & coupling constants
Factor orcoefficient
Dosimetry techniqueCalorimetry Fricke
dosimetryIon chamberdosimetry
M T∆ ODLρ
∆ Q
cdet C 13( )Fe Gε +
1 Wgasm egas
fmed Unity ( )medD Fricke
smed,gaspQ
3
Accurate clinical dosimetry, Part I, 2008 8
Interpretation of a dosimeter measurement (measurement at point r)
Ddet
• smed,det is the stopping power ratio medium to cavity material• pQ is an overall perturbation correction factor that accounts for everything acavity theory does not account for.
fmed
fmed is the ratio of dose to medium to dose to cavity; factorization of fmed isquestionable in regions of strong disequilibrium
Dmed (r ) = cdetM(r )smed,det(r )pQ(r )
• cdet is the detector dose calibration factor and ties the clinical dosemeasurement to the chamber/detector calibration; for ionization chamber:“cavity gas calibration coefficient”
• M is the result of a measurement corrected for “technical” influencequantities to ensure that what we actually measure a quantity proportional tothe dose to the detector material
Accurate clinical dosimetry, Part I, 2008 9
Reference dosimetry:TG-51 calibration protocol
• Cavity gas calibration coefficient derived froman absorbed dose to water calibration at 60Co
cdet =ND,w
Co
sw,air pQ( )Co
( =a.k.a
ND,air = Ngas )
Dw =ND,w
Co
sw,air pQ( )Co
Msw,air pQ
= ND,wCo MkQ kQ =
sw,air pQ
sw,air pQ( )Co
= fw( )CoQ
with
Accurate clinical dosimetry, Part I, 2008 10
calibration beamair kermacalibrationcoefficient
cavity gascalibrationcoefficient
absorbeddose calibrationcoefficient
clinical beamabsorbeddose calibrationcoefficient
Calibration chain for ionization chambers
Accurate clinical dosimetry, Part I, 2008 11
,D air gasN or N
Qkor
50' * *R ecal grk k P
,CoD wN
TG-51 or TRS 398
K XN or NTG-21 or TRS 277
,D wN
( )/ waterwall replairL P Pρ
4
Accurate clinical dosimetry, Part I, 2008 12
Reference dosimetry:TG-51 calibration protocol (photons)
Dw = MND,wCo kQ
- Measurement at 10cm depth in water- 10 x 10 cm2 field- beam quality specifier:%ddx(10 cm)
Almond et al, 1999
Accurate clinical dosimetry, Part I, 2008 13
Reference dosimetry:TG-51 calibration protocol (electrons)
Dw = MND,wCo kecalk 'R50
Pgr- Measurement at dref in water- 10 x 10 cm2 or 20 x 20 cm2 field- beam quality specifier: R50
Accurate clinical dosimetry, Part I, 2008 14
Reference DosimetryNew developments - WGTG51
• A number of more recent chamber types arenot listed in TG-51
• Extensive experimental data on kQ factors isavailable that allows to estimate uncertaintieson kQ as well as the overall referencedosimetry calibration process.
→ AAPM Work Group (WGTG51, chaired by M.McEwen) to supply this information (See importantpresentation: McEwen and Rogers, TH-D-352-2)
Accurate clinical dosimetry, Part I, 2008 15
Accuracy of clinical dosimetry
• Stability, linearity, reproducibility of the detector and themeasurement setup
• Energy dependence - what is the accuracy with which one canconvert detector dose to medium dose?
– CPE or TCPE and detector is small compared to the range of secondaryelectrons:
• fmed can be factorized as a stopping power ratio + correction factors (and thecorrections are small or constant)
– If these conditions are not fulfilled:• fmed cannot be factorized or very large correction and situation dependent
correction factors are needed (unpractical)
• Monte Carlo calculations (assumed accurate within the constraints of thealgorithm and basic cross-section datasets)
• Choose a more suitable detector (perturbation free, medium equivalent, etc)
5
Accurate clinical dosimetry, Part I, 2008 16
Why do we worry about CPE or TCPE?For the measurement of a dose distribution or for
measurement of output:• In regions of CPE and TCPE: SPR corrections
accurately represent detector response (and aresmall for air-filled chambers in photon beams)
• In regions of non-CPE: SPR corrections DO NOTaccurately reflect changes in detector response andadditional, sometimes large, corrections are needed– build-up regions in any field, interface-proximal points in
heterogeneous phantoms (build-up and build-down)– narrow stereotactic fields– intensity modulated fields
Accurate clinical dosimetry, Part I, 2008 17
Different measurement issues in open photon fields in water
• in-field, CPE or TCPE– standard measurement, SPR is nearly constant and represents
detector response well; detector perturbations are small (point-of-measurement shift is 0.6*rinner upstream)
• in-field, non-CPE (build-up)– non standard measurement, SPR varies modestly but does not
represent variation in detector response well; detector perturbationsare large, detector dependent.
• penumbra (non-CPE)– detector size must be small relative to field-size and penumbra
width, SPR does not represent detector response well, lateralfluence perturbations, detector dependent.
• out-of-field (CPE or TCPE)– detector size must be sufficiently large to collect sufficiently large
signal. SPR represents detector response well.
Accurate clinical dosimetry, Part I, 2008 18
Stopping power ratios (SPR’s)• SPR’s are depth, field size, and radiation quality
dependent– for reference dosimetry: values have been calculated with
Monte Carlo techniques and are well documented instandard dosimetry protocols
– for relative dosimetry in TCPE: their variation relative to thereference point can be calculated using Monte Carlotechniques
– for relative dosimetry in non-equilibrium situations: theirvariation relative to the reference point can still be calculatedbut no longer represents an accurate dose conversion.
Andreo and Brahme, Phys. Med. Biol. , 31, 839 (1986)
sw,air(z) for plane parallel bremsstrahlung beams- no e - contamination, central axis
10 MV
20 MV
30 MV
60Co
6
Accurate clinical dosimetry, Part I, 2008 20
Sanchez-Doblado et alPhys. Med.Biol. 48 2081-2099 (2003)
Smallfields
Accurate clinical dosimetry, Part I, 2008 21
Narrow 1.5 mm fieldRatio of dose to water to dose to air
Off-axis distance (mm)
Collecting electrodediameter: 1.5 mmSeparation: 1 mm
0.80
0.90
1.00
1.10
1.20
1.30
1.40
1.50
1.60
1.70
0 2 4 6 8
Dw/D
air
stopping powerratio w/air
averaged over cavity volume
Paskalev, Seuntjens,Podgorsak (2002) AAPM
Proc. Series 13, Med.Phys. Publishing,
Madison, Wi, 298 – 318.
Accurate clinical dosimetry, Part I, 2008 22
Perturbation correction factors: traditional factorization for ionization
chambers:
• Pwall: wall perturbation correction factor (pwall)• Pgr: correction for gradient effect (effective p. of
meas., pdis)• Pfl: fluence perturbation correction factor (pcav)• Pcel: central electrode perturbation correction factor
(pcel)
PQ = PwallPgrPflPcel
Accurate clinical dosimetry, Part I, 2008 23
Perturbation correction factors
• depth, field size, and radiation qualitydependent– for reference dosimetry using ionization chambers:
based on Monte Carlo calculations,measurements and relatively well documented
– for relative dosimetry: their variation relative to thereference point is traditionally ignored but can bevery significant in non-CPE conditions.
7
Buckley and Rogers, Med. Phys. 33 1788 - 1796 (2006)
NACP chamber in 6 MeV and 20 MeV electrons
Verhaegen et al, Phys. Med. Biol. 51 1221-1235 (2006)
NACP-02
Partialcompensation of wall andfluenceperturbationeffects
Accurate clinical dosimetry, Part I, 2008 26
Build-up dose measurements• Measurements are needed to ensure a
treatment planning system accuratelycalculates dose in the build-up region.
• The behaviour of ionization chambers in thebuild-up region is questionable.
Accurate clinical dosimetry, Part I, 2008 27
8
Accurate clinical dosimetry, Part I, 2008 28 Accurate clinical dosimetry, Part I, 2008 29
NACP chamber response in buildup region
cavair air
Q WD
m e
=
max max
( ) ( )
( ) ( )
cav
cav
D d Q d
D d Q d=
NACPmeasurementaccurate DOSRZnrc cavity
simulations
69.0 ± 0.3 %67 ± 2 %40x40
47 ± 2 %45 ± 1 %10x10
Measured relative surfaceionization
Calculated relativesurface cavity dose
Field size(cm2)
Accurate clinical dosimetry, Part I, 2008 30
Perturbation correction factors – 10x10 cm2
( )( ) ( ) ( )water
watercavwater airair
L dD d D d dρ
= Φ
0.78 ± 0.020.0
0.99± 0.0081.5
Perturbation correctionDepth (cm)
Accurate clinical dosimetry, Part I, 2008 31
9
Accurate clinical dosimetry, Part I, 2008 32
Kawrakow (2006) Med. Phys. 33, 1829
Reconcilingmeasurements andcalculations in thebuild-up region byadjusting EPOM
→simple if it works;but is chamberdependent!
Effective point of measurement in build-up region isnot the same as in CPE conditions
18 MV
McEwen et al (Med. Phys. 35, 950 (2008) )
Experimental shifts of point of measurement
Inflection point variabilityMatch @ inflection point
Ververs, Siebers and Kawrakow 2008 - TU-C-AUD B-1Accurate clinical dosimetry, Part I, 2008 35
Reference dosimetry in TG-51/TRS-398 non-compliant beams
• Many radiation treatment machines cannot producereference field sizes or SSDs according to therecommendations of TG-51 or TRS-398 protocols(e.g., GammaKnife, CyberKnife, and TomoTherapy).
• IMRT/IMRS and SRS/SRT/SBRT treatment plans aredesigned to treat from multiple beam directions.
• Delivery of these plans use small fields that are notvery similar to the reference conditions used forbeam calibration.→ Reference conditions for beam calibration should be as
close as possible to the patient irradiation conditions.
10
Accurate clinical dosimetry, Part I, 2008 36
Reference dose measurements in dynamic fields
Fraser, D. et al.,(2007)
0.85
0.90
0.95
1.00
1.05
1.10
0 10 20 30 40 50Plan No.
(DC/D
mea
s)IM
RT
Pin PointIC10NE2571 =
=0.973
( ) 0.022NE
NE
x
s x
==
0.963
( ) 0.024IC10
IC10
x
s x==
0.944
( ) 0.035PP
PP
x
s x
Accurate clinical dosimetry, Part I, 2008 37
6.9%1.0051.079 ± 5.9%Dynamic #8
5.9%1.0141.077 ± 5.7%Dynamic #7
-1.4%1.6051.583 ± 5.9%Dynamic #6
3.8%0.8850.920 ± 5.4%Dynamic #5
-2.4%1.0311.007 ± 3.2%Dynamic #4
7.8%1.0041.089 ± 3.9%Dynamic #3
0.7%1.1611.169 ± 2.5%Dynamic #2
-0.3%1.1431.139 ± 3.0%Dynamic #1
2.7%1.1411.172 ± 2.5%Static #5
3.2%1.2331.274 ± 6.0%Static #4
2.7%1.0941.124 ± 3.2%Static #3
1.9%1.1501.173 ± 6.1%Static #2
6.8%0.9501.019 ± 4.0%Static #1
Dif ferenceCIMRT,6 MVcalculatedCIMRT,6 MV
measuredField name
Correction to chamber measurements in IMRT fields
Bouchard and Seuntjens, MedPhys 31, 2453-2464 (2004)
Accurate clinical dosimetry, Part I, 2008 38
• IAEA - AAPM joint initiative– IAEA has had two consultancy meetings to
develop the protocol (Dec 07, May 08)– AAPM Workgroup on non-compliant beam
dosimetry– IPEM endorsement expected– Other national organizations to follow
• An international protocol that forms asupplement to existing protocols
Reference dosimetry protocol
Accurate clinical dosimetry, Part I, 2008 39
• Two new reference fields:– Small static field dosimetry: machine-specific-
reference field (msr) for treatment machines thatcannot establish a conventional reference field.
– Composite (dynamic) field dosimetry: plan-classspecific reference field (pcsr). Represents a classof dynamic or step-and-shoot delivery fields, or acombination of fields, such that full chargedparticle equilibrium (CPE) is achieved at theposition of the detector.
Reference dosimetry protocol
11
Accurate clinical dosimetry, Part I, 2008 40
1.8 cm
6 cm
Accurate clinical dosimetry, Part I, 2008 41
Accurate clinical dosimetry, Part I, 2008 42
Physics behind the conversion factors
from measurements using aprimary absorbed dose standard
from measurementsusing a “suitable”detector
from Monte Carlocalculations or othermodel
Accurate clinical dosimetry, Part I, 2008 43
Example: Tomotherapy calibration
0.997Helical, 1 cm0.9902 cm x 2 cm
1.000Helical, 2.5 cm0.99310 cm x 2 cm
1.000Helical, 5 cm0.99710 cm x 5 cm
fpcsr (route2)
Duaneet al, 2006
fmsr (route1)
Jeraj et al, 2005
12
Accurate clinical dosimetry, Part I, 2008 44
Discussion: defining a pcsr field
• minimize disequilibrium effects near detector• delivery of pcsr must resemble delivery of actual plans
corresponding to the same class• measurements in solid phantoms
→ Design treatment plan for pcsr :→ must preserve the essence of the modulation→ conversion factors can be accurately measured or calculated
→ Patient-specific QA procedure is much closer to pcsr than to reffield.
Accurate clinical dosimetry, Part I, 2008 45
Summary• Reviewed
– basics of dosimetry– TG-51 and current extensions– applicability of cavity theory to non-reference conditions
illustrated via small fields, build-up dose and non-compliantbeams
• accurate measurements require accurateunderstanding of the detector response
• conventional cavity theory for detector response isnot accurate in non-equilibrium conditions
• this has, in some cases, significant clinical impact ona dose measurement
• “suitable detectors” or “corrections” are needed